Veterinary Antimicrobial Susceptibility Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type (Livestock Animals, Companion Animals), By Product (Disks & Plates, Culture Media, Accessories & Consumables, Automated AST Instruments), By End Use (Veterinary Reference Lab, Veterinary Research Institutes, Others), By Region and Competition, 2020-2030F

Market Overview

The Global Veterinary Antimicrobial Susceptibility Testing Market, valued at USD 41.10 Billion in 2024, is projected to experience a CAGR of 6.03% to reach USD 58.40 Billion by 2030. Veterinary Antimicrobial Susceptibility Testing (AST) encompasses in vitro methods used to determine bacterial susceptibility to antimicrobial agents, thereby enabling veterinary professionals to select optimal treatments and monitor the development of antimicrobial resistance. The market’s growth is fundamentally driven by the escalating global prevalence of antimicrobial resistance in animal populations and the increasing demand for animal-derived food products. Furthermore, stringent regulatory initiatives promoting responsible antibiotic stewardship and a heightened awareness among veterinarians concerning the importance of AMR surveillance are key supporting factors.

According to the European Medicines Agency (EMA), in its first ESUAvet annual surveillance report published in March 2025, sales of antibiotics for food-producing animals accounted for 98% of total EU sales of veterinary medicines containing antibiotic activity in 2023. A notable challenge impeding market expansion, however, is the substantial cost associated with advanced or automated AST systems and their specialized reagents.

Key Market Drivers

The threat of antimicrobial resistance (AMR) in animals is a pivotal driver for the veterinary antimicrobial susceptibility testing market. Antibiotic misuse has fostered resistant bacterial strains, complicating treatment and necessitating precise diagnostic tools. Veterinary antimicrobial susceptibility testing offers crucial insights into pathogen profiles and their sensitivity to antimicrobials, enabling informed treatment and responsible stewardship. The urgent need to monitor and mitigate resistant microbe spread directly fuels demand for advanced AST solutions. According to HealthforAnimals, in its 2023 'Global Trends in Animal Antibiotic Use' report, the relative share of antimicrobials in leading animal health companies' product portfolios declined by 39% since 2013, indicating a strategic shift towards preventative diagnostics.

Concurrently, rising global demand for animal-derived food products significantly contributes to market expansion. Population growth drives increased meat, dairy, and aquaculture consumption, leading to intensified livestock farming. Animal concentration heightens disease transmission risks, requiring proactive health management and routine veterinary antimicrobial susceptibility testing for animal health and food safety. Accurate diagnostics are essential for maintaining herd productivity in large-scale operations. According to the Food and Agriculture Organization (FAO), in a 2024 outlook, global meat production was forecast to reach 373 million tonnes in 2024, an increase of 1.4% from 2023, underscoring the expanding animal population needing robust diagnostics. This sustained agricultural activity, coupled with broader industry growth, highlights the market’s positive trajectory. For instance, according to Zoetis's 2024 Annual Report, the company grew its revenue by 11% operationally in 2024, demonstrating robust performance within the animal health industry.

Download Free Sample Report

Key Market Challenges

The substantial cost associated with advanced or automated Antimicrobial Susceptibility Testing (AST) systems and their specialized reagents represents a significant impediment to the growth of the Global Veterinary Antimicrobial Susceptibility Testing Market. This financial barrier directly limits the adoption of these modern diagnostic technologies, particularly among smaller veterinary practices, independent clinics, and those operating in developing regions where capital expenditure budgets are constrained. The high initial investment, coupled with ongoing costs for maintenance and proprietary reagents, makes it challenging for many veterinary professionals to acquire and utilize these crucial tools.

Despite a rising demand for comprehensive animal healthcare services, the prohibitive expense of advanced AST systems prevents their widespread implementation. For instance, according to the American Pet Products Association (APPA), US pet ownership reached 70% in 2024, indicating a large population of companion animals requiring veterinary care. However, the cost of specialized AST equipment can divert financial resources or defer investment, leading to continued reliance on traditional, slower, or less accurate manual testing methods. This directly hampers efforts to efficiently monitor and combat antimicrobial resistance in animal populations, potentially delaying optimal treatment decisions and impacting overall animal health outcomes.

Key Market Trends

The Global Veterinary Antimicrobial Susceptibility Testing Market is significantly influenced by the growing emphasis on One Health harmonization of surveillance. This approach recognizes the interconnectedness of human, animal, and environmental health, driving coordinated efforts to monitor and combat antimicrobial resistance. Such harmonization ensures a more comprehensive understanding of resistance patterns across species, enabling more effective interventions and policy development. According to the World Health Organization, in November 2023, 178 countries had developed national action plans for antimicrobial resistance that align with the Global Action Plan, which inherently emphasizes a One Health approach. This commitment fosters cross-sectoral collaboration, directly impacting the demand for standardized veterinary AST solutions that can contribute data to integrated surveillance systems. The World Organisation for Animal Health further enhanced its One Health initiatives in September 2024 by launching the Performance of Veterinary Services Information System, designed to improve access to data regarding Veterinary Services’ One Health competencies.

Concurrently, the increasing adoption of automated testing instruments is a pivotal trend transforming the veterinary AST market. Automated systems enhance efficiency and accuracy in diagnostic workflows, reducing manual errors and accelerating turnaround times for susceptibility results. This technological shift enables veterinary professionals to make timely and informed treatment decisions, critical for effective antimicrobial stewardship. According to HealthforAnimals, in its 2023 "Roadmap Progress Report", 28 new diagnostic tools were introduced to the market since November 2019, reflecting ongoing innovation in animal health diagnostics. This continued development and market introduction drive the demand for sophisticated automated platforms capable of high-throughput analysis. Zoetis further demonstrated advances in automated diagnostics, as noted in an October 2024 DVM360 article, showcasing its Virtual Laboratory which leverages artificial intelligence for tasks such as blood smear testing on the Vetscan Imagyst platform.

Segmental Insights

The Companion Animals segment is emerging as the fastest-growing area within the Global Veterinary Antimicrobial Susceptibility Testing Market. This accelerated growth is primarily driven by the escalating global trend of pet ownership, where companion animals are increasingly regarded as integral family members, prompting greater willingness among owners to invest in advanced veterinary care and diagnostic services. Concurrently, a heightened awareness regarding the prevalence of antimicrobial resistance in pets, and its potential public health implications, is significantly fueling the demand for accurate antimicrobial susceptibility testing. Such testing is crucial for guiding appropriate treatment decisions and promoting responsible antibiotic stewardship, often supported by guidelines from organizations like the Clinical Laboratory and Standards Institute.

Regional Insights

Asia Pacific dominates the Global Veterinary Antimicrobial Susceptibility Testing Market due to several key factors. The region is home to the world's largest livestock population, driving substantial demand for animal health diagnostics to ensure food safety and productivity. This extensive animal agriculture, alongside increasing pet ownership and associated health expenditure, fuels the need for effective antimicrobial susceptibility testing. Furthermore, heightened awareness of antimicrobial resistance and its widespread implications has spurred proactive government initiatives. Organizations like the Federation of Asian Veterinary Associations actively implement policies and strategies to promote responsible antimicrobial use and enhance surveillance, accelerating the adoption of testing technologies and contributing significantly to the market's growth across the region.

Recent Developments

• In July 2025, a research team from SRUC, in collaboration with the UK Government's Veterinary Medicines Directorate (VMD), commenced a pioneering national surveillance program in the United Kingdom. This initiative represents the world's first study dedicated to monitoring antibiotic resistance levels in healthy populations of cats and dogs, directly influencing the Global Veterinary Antimicrobial Susceptibility Testing Market. The program aims to gather comprehensive data on antimicrobial resistance prevalence in companion animals, informing strategies to mitigate infection risks for both animals and humans. This breakthrough research builds upon existing surveillance efforts and addresses surveillance gaps in animal populations.

• In November 2024, FunKeep introduced its VetPanel Antimicrobial Susceptibility Test Kit at MEDICA 2024, directly impacting the Global Veterinary Antimicrobial Susceptibility Testing Market. This new product aims to address antibiotic resistance in pets by offering a comprehensive 24-drug panel covering common pathogens. The VetPanel evaluates inhibition zones in under five minutes, providing evidence-based treatment protocols with a 99.3% accuracy rate, which surpasses traditional methods. The company secured cooperation agreements with several customers, targeting over 500 clinics in 2025 for the adoption of this testing solution.

• In January 2024, Center Point Bio-Tech, LLC (CPB) successfully launched its AlphaION veterinary diagnostic system at the Veterinary Meeting & Expo, expanding its presence in the Global Veterinary Antimicrobial Susceptibility Testing Market. This patented system provides in-hospital automation for bacterial culture and sensitivity testing, a process traditionally sent to external reference laboratories. AlphaION's innovative design enables veterinarians to perform rapid and accurate antimicrobial susceptibility testing on-site. The introduction of this system is expected to improve antimicrobial stewardship by facilitating timely and appropriate antibiotic prescriptions for animal patients.

• In 2024, bioMérieux obtained 510(k) clearance from the FDA for its VITEK® REVEALTM system, marking a significant development in the Global Veterinary Antimicrobial Susceptibility Testing Market. This innovative solution, developed following the 2022 acquisition of Specific Diagnostics, provides rapid antimicrobial susceptibility testing directly from positive blood cultures for Gram-negative bacteria. The system delivers usable results in approximately five to six hours, enabling faster therapeutic decision-making for patients with bacteremic sepsis. This advancement reinforces bioMérieux's commitment to combating antimicrobial resistance and enhancing diagnostic capabilities in clinical microbiology.

Key Market Players

• Becton, Dickinson and Company
• BioMérieux SA
• Synbiosis Ltd.
• Thermo Fisher Scientific Inc.
• Bruker Corporation
• Danaher Corporation
• LABORATORIOS CONDA, S.A
• Bioguard Corporation
• Liofilchem S.r.l.

Report Scope:

In this report, the Global Veterinary Antimicrobial Susceptibility Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Veterinary Antimicrobial Susceptibility Testing Market, By Animal Type:

o   Livestock Animals

o   Companion Animals

• Veterinary Antimicrobial Susceptibility Testing Market, By Product:

o   Disks & Plates

o   Culture Media

o   Accessories & Consumables

o   Automated AST Instruments

• Veterinary Antimicrobial Susceptibility Testing Market, By End Use:

o   Veterinary Reference Lab

o   Veterinary Research Institutes

o   Others

• Veterinary Antimicrobial Susceptibility Testing Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Veterinary Antimicrobial Susceptibility Testing Market.

Available Customizations:

Global Veterinary Antimicrobial Susceptibility Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Veterinary Antimicrobial Susceptibility Testing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]